论文部分内容阅读
摘要目的评估III期非小细胞肺癌(NSCLC)病人治疗前的正电子发射体层成像(PET)定量成像特征是否能够超越传统预测方法,从而提高病人的总体生存危险分级。材料与方法机构伦理委员会已通过这项回顾性图表研究,并放弃对获得病人知情同意的要求。作者回顾性选取195例2008
Abstract Objective To evaluate whether positron emission tomography (PET) quantitative imaging before treatment in patients with stage III non-small cell lung cancer (NSCLC) can surpass the traditional prediction methods to improve the patient’s overall survival risk classification. Materials and Methods The Institutional Ethics Committee passed the retrospective chart study and waived the requirement to obtain informed consent from patients. The authors retrospectively selected 195 cases of 2008